BerandaINO • NASDAQ
add
Inovio Pharmaceuticals Inc
Tutup sebelumnya
$1,33
Rentang hari
$1,33 - $1,38
Rentang tahun
$1,30 - $12,33
Kapitalisasi pasar
69,28Â jt USD
Volume Rata-Rata
1,84Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 65,34 rb | — |
Biaya operasional | 9,02Â jt | -14,63% |
Laba bersih | -19,69Â jt | 35,36% |
Margin laba bersih | -30,14 rb | — |
Penghasilan per saham | -0,51 | 61,07% |
EBITDA | -24,68Â jt | 20,54% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 68,36Â jt | -35,27% |
Total aset | 87,27Â jt | -32,41% |
Total liabilitas | 36,02Â jt | 3,89% |
Total ekuitas | 51,25 jt | — |
Saham yang beredar | 36,67 jt | — |
Harga terhadap nilai buku | 0,95 | — |
Tingkat pengembalian aset | -62,48% | — |
Tingkat pengembalian modal | -87,66% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,69Â jt | 35,36% |
Kas dari operasi | -26,87Â jt | 6,56% |
Kas dari investasi | -51,75Â rb | -100,11% |
Kas dari pembiayaan | 1,03Â jt | 109,05% |
Perubahan kas bersih | -25,90Â jt | -589,47% |
Arus kas bebas | -21,47Â jt | -26,75% |
Tentang
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Situs
Karyawan
134
